| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Ocular Surface and Tear Center, Department of Ophthalmology, Bascom Palmer Eye Institute; and the 2 Department of Urology, University of Miami School of Medicine, Florida.
PURPOSE. To evaluate human corneal epithelial culture supernatant and tear fluid for the presence of activators and inhibitors of matrix metalloproteinase (MMP)-9, MMP-3, and tissue inhibitor of metalloproteinase (TIMP)-1, respectively, and to evaluate the effect of MMP-3 on the activation of MMP-9 in these specimens.
METHODS. Unstimulated tear fluid was collected from patients with ocular rosacea and normal control subjects. Levels of MMP-9, MMP-3, and TIMP-1 were determined by enzyme-linked immunosorbent assay (ELISA) and/or immunoblot analysis. Supernatants from primary human corneal epithelial cultures and human tear fluid were incubated with MMP-3. Cultured epithelial cells and their supernatants were also treated with doxycycline before MMP-3 was added. Gelatin zymography was used to identify activated 82-kDa MMP-9. MMP-9 activity was assessed with a commercial MMP-9 activity assay system.
RESULTS. MMP-9 and TIMP-1 were detected at significantly higher concentrations in rosacea-affected than in normal tear fluids. MMP-3 was detected exclusively in the tear fluid of patients with ocular rosacea who had corneal epithelial disease. Treatment of the supernatant and tear fluid with MMP-3 resulted in two bands with molecular weights of 92 kDa and 82 kDa, representing pro-MMP-9 and activated MMP-9, respectively. Doxycycline added to the conditioned media did not affect activation of MMP-9 by MMP-3. However, 24-hour treatment of corneal epithelial cultures with doxycycline resulted in a lower concentration and activity of MMP-9 in their supernatants.
CONCLUSIONS. MMP-9 and TIMP-1 are produced by the human corneal epithelium and are present in tear fluid. MMP-3 alone is sufficient to activate MMP-9 on the ocular surface. Doxycycline does not directly inhibit this activation by MMP-3, but it decreases MMP-9 activity when added to corneal epithelial cultures.
This article has been cited by other articles:
|
|
 |
|
  V A Smith, D Khan-Lim, L Anderson, S D Cook, and A D Dick Does orally administered doxycycline reach the tear film? Br. J. Ophthalmol., June 1, 2008; 92(6): 856 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Blalock, S. J. Spurr-Michaud, A. S. Tisdale, and I. K. Gipson Release of Membrane-Associated Mucins from Ocular Surface Epithelia Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1864 - 1871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Hodgkinson, G. Duncan, L. Wang, C. J. Pennington, D. R. Edwards, and I. M. Wormstone MMP and TIMP Expression in Quiescent, Dividing, and Differentiating Human Lens Cells Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4192 - 4199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-C. Yoon, C. S. De Paiva, H. Qi, Z. Chen, W. J. Farley, D.-Q. Li, and S. C. Pflugfelder Expression of Th-1 Chemokines and Chemokine Receptors on the Ocular Surface of C57BL/6 Mice: Effects of Desiccating Stress Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2561 - 2569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. LaGier, S. H. Yoo, E. C. Alfonso, S. Meiners, and M. E. Fini Inhibition of Human Corneal Epithelial Production of Fibrotic Mediator TGF-{beta}2 by Basement Membrane-Like Extracellular Matrix Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1061 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. De Paiva, R. M. Corrales, A. L. Villarreal, W. Farley, D.-Q. Li, M. E. Stern, and S. C. Pflugfelder Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2847 - 2856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shoshani, J. Pe'er, V. Doviner, J. Frucht-Pery, and A. Solomon Increased Expression of Inflammatory Cytokines and Matrix Metalloproteinases in Pseudophakic Corneal Edema Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 1940 - 1947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-S. Kim, L. Luo, S. C. Pflugfelder, and D.-Q. Li Doxycycline Inhibits TGF-{beta}1-Induced MMP-9 via Smad and MAPK Pathways in Human Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 840 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Pflugfelder, W. Farley, L. Luo, L. Z. Chen, C. S. de Paiva, L. C. Olmos, D.-Q. Li, and M. E. Fini Matrix Metalloproteinase-9 Knockout Confers Resistance to Corneal Epithelial Barrier Disruption in Experimental Dry Eye Am. J. Pathol., January 1, 2005; 166(1): 61 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Luo, D.-Q. Li, A. Doshi, W. Farley, R. M. Corrales, and S. C. Pflugfelder Experimental Dry Eye Stimulates Production of Inflammatory Cytokines and MMP-9 and Activates MAPK Signaling Pathways on the Ocular Surface Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4293 - 4301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-Q. Li, Z. Chen, X. J. Song, L. Luo, and S. C. Pflugfelder Stimulation of Matrix Metalloproteinases by Hyperosmolarity via a JNK Pathway in Human Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4302 - 4311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mira, R. A. Lacalle, J. M. Buesa, G. G. de Buitrago, S. Jimenez-Baranda, C. Gomez-Mouton, C. Martinez-A, and S. Manes Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface J. Cell Sci., May 1, 2004; 117(9): 1847 - 1857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. J. Song, D.-Q. Li, W. Farley, L. H. Luo, R. O. Heuckeroth, J. Milbrandt, and S. C. Pflugfelder Neurturin-Deficient Mice Develop Dry Eye and Keratoconjunctivitis Sicca Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4223 - 4229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Q. Li, T. Y. Shang, H.-S. Kim, A. Solomon, B. L. Lokeshwar, and S. C. Pflugfelder Regulated Expression of Collagenases MMP-1, -8, and -13 and Stromelysins MMP-3, -10, and -11 by Human Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 2928 - 2936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Leonardi, P. Brun, G. Abatangelo, M. Plebani, and A. G. Secchi Tear Levels and Activity of Matrix Metalloproteinase (MMP)-1 and MMP-9 in Vernal Keratoconjunctivitis Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3052 - 3058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Holopainen, J. A. O. Moilanen, T. Sorsa, M. Kivela-Rajamaki, T. Tervahartiala, M. H. Vesaluoma, and T. M. T. Tervo Activation of Matrix Metalloproteinase-8 by Membrane Type 1-MMP and Their Expression in Human Tears after Photorefractive Keratectomy Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2550 - 2556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Schlotzer-Schrehardt, J. Lommatzsch, M. Kuchle, A. G. P. Konstas, and G. O. H. Naumann Matrix Metalloproteinases and Their Inhibitors in Aqueous Humor of Patients with Pseudoexfoliation Syndrome/Glaucoma and Primary Open-Angle Glaucoma Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1117 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Solomon, D. Dursun, Z. Liu, Y. Xie, A. Macri, and S. C. Pflugfelder Pro- and Anti-inflammatory Forms of Interleukin-1 in the Tear Fluid and Conjunctiva of Patients with Dry-Eye Disease Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2283 - 2292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Solomon, M. Rosenblatt, D.-Q. Li, Z. Liu, D. Monroy, Z. Ji, B. L. Lokeshwar, and S. C. Pflugfelder Doxycycline Inhibition of Interleukin-1 in the Corneal Epithelium Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2544 - 2557. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
